Search results

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 IPRO Day Presentation F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Abstract F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: Synthetic Biology: Engineering a Novel Organism (semester?), IPRO 302: Synthetic Biology IPRO 302 Poster Sp07
Creator: Sandulescu, Corina, Ruszczak, Christopher, Ervin, Natalia, Lim, Soo, Heller, Matthew, Kisiel, Greggory, Sharma, Shubhi, Vasireddi, Sunil, Lin, Jeffrey, Ingvoldstad, Bennett, Carlton, Kyle, Sobczck, Karol
Date: 2007-05, 2007-05
Description: Synthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes...
Show moreSynthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes and test it in a biological setting. This is in contrast to the reductionist approach where a complex pre-existing biological system is analyzed in an attempt to discover the purpose of each of the parts. In this IPRO, a very simple genetic system is being designed, built, and tested in a biological setting. Previous semesters have already accomplished such in bacteria. This semester's focus will be on building the system designed last semester and inserting it into an eukaryotic organism; the zebrafish. The main purpose of this IPRO is to advance the knowledge of biological systems and their manipulation. This is being done through the design and creation of a simple, but novel, genetic circuit, and the introduction of this circuit into an organism to observe its properties in vivo. In order to accomplish this goal, we have split up into 4 different sub-teams: Fish, Math Modeling, Futures and Design, and Construction
Deliverables for IPRO 302: Synthetic Biology: Engineering a Novel Organism for the Spring 2007 semester
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Poster F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: Synthetic Biology: Engineering a Novel Organism (semester?), IPRO 302
Creator: Sandulescu, Corina, Ruszczak, Christopher, Ervin, Natalia, Lim, Soo, Heller, Matthew, Kisiel, Greggory, Sharma, Shubhi, Vasireddi, Sunil, Lin, Jeffrey, Ingvoldstad, Bennett, Carlton, Kyle, Sobczck, Karol
Date: 2007-05, 2007-05
Description: Synthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes...
Show moreSynthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes and test it in a biological setting. This is in contrast to the reductionist approach where a complex pre-existing biological system is analyzed in an attempt to discover the purpose of each of the parts. In this IPRO, a very simple genetic system is being designed, built, and tested in a biological setting. Previous semesters have already accomplished such in bacteria. This semester's focus will be on building the system designed last semester and inserting it into an eukaryotic organism; the zebrafish. The main purpose of this IPRO is to advance the knowledge of biological systems and their manipulation. This is being done through the design and creation of a simple, but novel, genetic circuit, and the introduction of this circuit into an organism to observe its properties in vivo. In order to accomplish this goal, we have split up into 4 different sub-teams: Fish, Math Modeling, Futures and Design, and Construction
Deliverables for IPRO 302: Synthetic Biology: Engineering a Novel Organism for the Spring 2007 semester
Show less

Title: Synthetic Biology: Engineering a Novel Organism (semester?), IPRO 302: Synthetic Biology IPRO 302 Final Report Sp07
Creator: Sandulescu, Corina, Ruszczak, Christopher, Ervin, Natalia, Lim, Soo, Heller, Matthew, Kisiel, Greggory, Sharma, Shubhi, Vasireddi, Sunil, Lin, Jeffrey, Ingvoldstad, Bennett, Carlton, Kyle, Sobczck, Karol
Date: 2007-05, 2007-05
Description: Synthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes...
Show moreSynthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes and test it in a biological setting. This is in contrast to the reductionist approach where a complex pre-existing biological system is analyzed in an attempt to discover the purpose of each of the parts. In this IPRO, a very simple genetic system is being designed, built, and tested in a biological setting. Previous semesters have already accomplished such in bacteria. This semester's focus will be on building the system designed last semester and inserting it into an eukaryotic organism; the zebrafish. The main purpose of this IPRO is to advance the knowledge of biological systems and their manipulation. This is being done through the design and creation of a simple, but novel, genetic circuit, and the introduction of this circuit into an organism to observe its properties in vivo. In order to accomplish this goal, we have split up into 4 different sub-teams: Fish, Math Modeling, Futures and Design, and Construction
Deliverables for IPRO 302: Synthetic Biology: Engineering a Novel Organism for the Spring 2007 semester
Show less

Title: Synthetic Biology: Engineering a Novel Organism (semester?), IPRO 302: Synthetic Biology IPRO 302 IPRO Day Presentation Sp07
Creator: Sandulescu, Corina, Ruszczak, Christopher, Ervin, Natalia, Lim, Soo, Heller, Matthew, Kisiel, Greggory, Sharma, Shubhi, Vasireddi, Sunil, Lin, Jeffrey, Ingvoldstad, Bennett, Carlton, Kyle, Sobczck, Karol
Date: 2007-05, 2007-05
Description: Synthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes...
Show moreSynthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes and test it in a biological setting. This is in contrast to the reductionist approach where a complex pre-existing biological system is analyzed in an attempt to discover the purpose of each of the parts. In this IPRO, a very simple genetic system is being designed, built, and tested in a biological setting. Previous semesters have already accomplished such in bacteria. This semester's focus will be on building the system designed last semester and inserting it into an eukaryotic organism; the zebrafish. The main purpose of this IPRO is to advance the knowledge of biological systems and their manipulation. This is being done through the design and creation of a simple, but novel, genetic circuit, and the introduction of this circuit into an organism to observe its properties in vivo. In order to accomplish this goal, we have split up into 4 different sub-teams: Fish, Math Modeling, Futures and Design, and Construction
Deliverables for IPRO 302: Synthetic Biology: Engineering a Novel Organism for the Spring 2007 semester
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Midterm Presentation F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: Synthetic Biology: Engineering a Novel Organism (semester?), IPRO 302: Synthetic Biology IPRO 302 Project Plan Sp07
Creator: Sandulescu, Corina, Ruszczak, Christopher, Ervin, Natalia, Lim, Soo, Heller, Matthew, Kisiel, Greggory, Sharma, Shubhi, Vasireddi, Sunil, Lin, Jeffrey, Ingvoldstad, Bennett, Carlton, Kyle, Sobczck, Karol
Date: 2007-05, 2007-05
Description: Synthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes...
Show moreSynthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes and test it in a biological setting. This is in contrast to the reductionist approach where a complex pre-existing biological system is analyzed in an attempt to discover the purpose of each of the parts. In this IPRO, a very simple genetic system is being designed, built, and tested in a biological setting. Previous semesters have already accomplished such in bacteria. This semester's focus will be on building the system designed last semester and inserting it into an eukaryotic organism; the zebrafish. The main purpose of this IPRO is to advance the knowledge of biological systems and their manipulation. This is being done through the design and creation of a simple, but novel, genetic circuit, and the introduction of this circuit into an organism to observe its properties in vivo. In order to accomplish this goal, we have split up into 4 different sub-teams: Fish, Math Modeling, Futures and Design, and Construction
Deliverables for IPRO 302: Synthetic Biology: Engineering a Novel Organism for the Spring 2007 semester
Show less

Title: ACCELPharma (semester?), IPRO 353
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: Synthetic Biology: Engineering a Novel Organism (semester?), IPRO 302: Synthetic Biology IPRO 302 Midterm Report Sp07
Creator: Sandulescu, Corina, Ruszczak, Christopher, Ervin, Natalia, Lim, Soo, Heller, Matthew, Kisiel, Greggory, Sharma, Shubhi, Vasireddi, Sunil, Lin, Jeffrey, Ingvoldstad, Bennett, Carlton, Kyle, Sobczck, Karol
Date: 2007-05, 2007-05
Description: Synthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes...
Show moreSynthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes and test it in a biological setting. This is in contrast to the reductionist approach where a complex pre-existing biological system is analyzed in an attempt to discover the purpose of each of the parts. In this IPRO, a very simple genetic system is being designed, built, and tested in a biological setting. Previous semesters have already accomplished such in bacteria. This semester's focus will be on building the system designed last semester and inserting it into an eukaryotic organism; the zebrafish. The main purpose of this IPRO is to advance the knowledge of biological systems and their manipulation. This is being done through the design and creation of a simple, but novel, genetic circuit, and the introduction of this circuit into an organism to observe its properties in vivo. In order to accomplish this goal, we have split up into 4 different sub-teams: Fish, Math Modeling, Futures and Design, and Construction
Deliverables for IPRO 302: Synthetic Biology: Engineering a Novel Organism for the Spring 2007 semester
Show less

Title: ACCELPharma (semester?), IPRO 353: ACCELPharma IPRO 353 Final Report F06
Creator: Josefsson, Gustaf, Ames, Kerry, Calizo, Milagros, Schiller, Brian, Groth, Kristel, Ervin, Natalia, Holmes, Matt, Lee, Hyun, Lim, Eung, Ravi, Iyengar
Date: 2006-12, 2006-12
Description: AccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development,...
Show moreAccelPharma intends to enable pharmaceutical and biotech companies to reintroduce withdrawn drugs to the market place through the development, validation, and deployment of personalized medicine models. It differentiates itself by being one of the only companies to correlate side effects of drugs to certain genetic mutations for a broad range of effects. AccelPharma expects to break even and begin to achieve positive revenues after only the second sale.
Deliverables for IPRO 353: ACCELPharma for the Fall 2006 semester.
Show less

Title: Synthetic Biology: Engineering a Novel Organism (semester?), IPRO 302: Synthetic Biology IPRO 302 Abstract Sp07
Creator: Sandulescu, Corina, Ruszczak, Christopher, Ervin, Natalia, Lim, Soo, Heller, Matthew, Kisiel, Greggory, Sharma, Shubhi, Vasireddi, Sunil, Lin, Jeffrey, Ingvoldstad, Bennett, Carlton, Kyle, Sobczck, Karol
Date: 2007-05, 2007-05
Description: Synthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes...
Show moreSynthetic biology is a relatively new approach to genetic research where the focus is to build a simple genetic system with known processes and test it in a biological setting. This is in contrast to the reductionist approach where a complex pre-existing biological system is analyzed in an attempt to discover the purpose of each of the parts. In this IPRO, a very simple genetic system is being designed, built, and tested in a biological setting. Previous semesters have already accomplished such in bacteria. This semester's focus will be on building the system designed last semester and inserting it into an eukaryotic organism; the zebrafish. The main purpose of this IPRO is to advance the knowledge of biological systems and their manipulation. This is being done through the design and creation of a simple, but novel, genetic circuit, and the introduction of this circuit into an organism to observe its properties in vivo. In order to accomplish this goal, we have split up into 4 different sub-teams: Fish, Math Modeling, Futures and Design, and Construction
Deliverables for IPRO 302: Synthetic Biology: Engineering a Novel Organism for the Spring 2007 semester
Show less

repository.iit

Search the repository

Enabled Filters

Refine Results

Type

Date

Department

Subject

Creator

Rights